OGN
#1579
Organon & Co. Common Stock
13.7 7 USD
0.00%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
+0.07%
Monthly Change
+1.62%
6 month change
+95.04%
Year Change
+89.67%
Previous Close
13.7 6
Open
13.7 7
Low
13.7 6
High
13.7 7
Volume
565
Financials
- Market Capitalization 3.62 B
- Employee 10 K
- Founded N/A
- CEO N/A
- Website www.organon.com
- Headquarter New Jersey, United States
- FIGI BBG00ZQRGW24
- Industry Drug Manufacturers—General
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
9.96
Price to sales ratio
0.3
Dividends per share
0.34
Dividend yield %
4.74
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 1219 |  ORKA Oruka Therapeutics, Inc. - Common Stock | 91.15 USD | -5.58% | -14.61% | +0.92% | +184.22% | 6.04 B USD | ||
| 1497 |  MANE Veradermics, Incorporated Common Stock | 97.84 USD | -3.69% | -4.65% | -10.11% | +196.48% | 4.09 B USD | ||
| 1716 |  MBX MBX Biosciences, Inc. - Common Stock | 63.00 USD | -5.11% | -4.88% | -2.84% | +321.69% | 3.03 B USD | ||
| 1896 |  RAPP Rapport Therapeutics, Inc. - Common Stock | 48.77 USD | -4.05% | +1.27% | +16.98% | +86.22% | 2.34 B USD |
Frequently asked questions about Organon & Co.
What is the Organon & Co. stock price today?
The current price of Organon & Co. (OGN) is 13.77. Over the past 24 hours, the stock has changed by +0.07%. Follow the OGN chart for real-time price dynamics.
What is the stock ticker of Organon & Co.?
Organon & Co. trades under the ticker OGN. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Organon & Co. stock going up?
OGN has changed by +0.22% over the last week, +1.62% over the last month, and +89.67% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Organon & Co.?
Organon & Co. currently has a market capitalization of 3.62 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
Does Organon & Co. release financial reports?
Yes. You can track Organon & Co. financial reports and review yearly or quarterly fundamentals on metatrader.com, including revenue, net income, dividends, and valuation metrics.
What were Organon & Co. earnings last quarter?
Last quarter, Organon & Co. reported earnings of 0.41 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Organon & Co. revenue for the last quarter?
Organon & Co. reported quarterly revenue of 1.56 B. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Organon & Co. net income for the last quarter?
Organon & Co. reported net income of 108 M for the last quarter. The previous quarter showed 146 M, which means net income changed by -26.03%.
Does Organon & Co. pay dividends?
Organon & Co. paid a dividend per share of 0.02. The current dividend yield is 2.95%. Dividend data can help income-focused investors evaluate the stock.
Is Organon & Co. a good dividend stock?
Organon & Co. currently has a dividend yield of 2.95%. Previously, the dividend yield was 6.68%, compared with 4.74% a year earlier. When evaluating dividend stocks, investors should also consider earnings, cash flow, and the sustainability of future dividend payments.
How many employees does Organon & Co. have?
As of the latest available data, Organon & Co. has 10 K employees. Workforce size can provide additional context about the company's scale and operations.
What is Organon & Co. EBITDA?
Organon & Co. EBITDA is 403 M, and its EBITDA margin is 25.87%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Organon & Co. stock?
You can buy Organon & Co. (OGN) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Organon & Co. stock?
Investing in Organon & Co. requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the OGN chart and related analysis on metatrader.com as part of your research.